Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient

Nephrology Dialysis Transplantation

Volumn 11, Issue 7, 1996, Pages 1367-1370

  Sturm, I ^a   Watschinger, B ^a   Geissler, K ^a   Guber, S E ^b   Popow Kraupp, T ^c   Horl W H ^a   Pohanka, E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Immunoglobulin; Parvovirus B19; Pure red cell anaemia; Renal transplantation

Indexed keywords

IMMUNOGLOBULIN;

ADULT; ARTICLE; CASE REPORT; ERYTHEMA INFECTIOSUM; ERYTHROCYTE; FEMALE; HUMAN; IMMUNOTHERAPY; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; PARVOVIRUS; PRIORITY JOURNAL; PURE RED CELL ANEMIA;

EID: 0030015362     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.7.1367     Document Type: Article

References (19)

1. Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet 1975; 1: 72-73
2. Anderson MJ, Jones SE, Fisher-Hoch SP et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983; 1: 1378
3. Young NS, Mortimer PP, Moore JG, Humphries RK. Characterization of a virus that causes transient aplastic crisis. J Clin Invest 1984; 73: 224-230
4. Saarinen UM, Chorba TL, Tattersall P et al. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood 1986; 67: 1411-1417
5. Schwarz TF, Roggendorf M, Janka-Schaub G. Aplastic crisis caused by parvovirus B19. Eur J Clin Microbiol 1988; 7: 87-88
6. Nour B, Green M, Michaels M et al. Parvovirus B19 infection in pediatric transplant patients. Transplantation 1993; 56: 835-838
7. Ramage JK, Hale A, Gane E et al. Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin [letter]. Lancet 1994; 343: 667-668
8. Cantu TG, Hoehn-Saric EW, Burgess KM, Racusen L. Scheel PJ. Acute renal failure associated with immunoglobulin therapy. Am J Kidney Dis 1995; 25: 228-234
9. Winkler M, Schulze F, Jost U, Ringe B, Pichlmayr R. Anaemia associated with FK506 immunosuppression [letter]. Lancet 1993; 341: 1035-1036
10. Pattison JR. Diseases caused by the human parvovirus B19. Arch Dis Child 1988; 63: 1426-1427
11. Young N, Mortimer P. Viruses and bone marrow failure. Blood 1984; 63: 729-737
12. Frickhofen N, Chen ZJ, Young NS, Cohen BJ, Heimpel H, Abkowitz JL. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol 1994; 87: 818-824
13. Van HD, Mortimer PP, Young N, Hanson GR. Human parvovirus-associated red cell aplasia in the absence of underlying hemolytic anemia. Am J Pediatr Hematol Oncol 1986; 8: 235-239
14. Taillan B, Heudier P, Ferrari E, Gamier G, Fuzibet JG, Dujardin P. Pure red-cell aplasia due to parvovirus B19 infection in a patient with AIDS-related complex. Ann Med 1992; 24: 18-20
15. Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med 1989; 321: 519-523
16. Frickhofen N, Abkowitz JL, Safford M et al. Persistent B19 parvovirus infection in patients infected with human immuno-deficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990; 113: 926-933
17. Koch WC, Massey G, Russell CE, Adler SP. Manifestations and treatment of human parvovirus B19 infection in immuno-compromised patients. J Pediatr 1990; 116: 355-359
18. Gottlieb F, Deutsch J. Red cell aplasia responsive to immunoglobulin therapy as initial manifestation of human immuno-deficiency virus infection. Am J Med 1992; 92: 331-333
19. Freedman MH. Pure red cell aplasia in childhood and adolescence: pathogenesis and approaches to diagnosis. Br J Haematol 1993; 85: 246-253